New York-based 22nd Century Group said it intends to sell off its GVB Biopharma unit, a CBD maker, with the price tag estimated at $2.25 million – after having purchased …
New York biotech company takes massive loss in selloff of CBD unit Read More »
The takeover of Silicon Valley Bank (SVB) branches by First Citizens Bank could help hemp companies in a number of states where the North-Carolina-based regional bank previously had no presence. …
Bank takeover could help more hemp producers, but overall reform still needed Read More »
The Scottish National Investment Bank has boosted its investment in an Edinburgh company that makes hemp fiber-based insulation for the construction industry. The bank announced it has added £2 million …
Scottish bank raises investment in hemp insulation maker to £5 million Read More »
A Korean pharmaceutical maker said it will partner with a Japanese company to complete development of a CBD “film” for oral intake. CTC Bio, Gyeonggi-do province in Korea, said Japan’s …
Korean, Japanese partners to make, distribute advanced oral CBD product Read More »
Colorado-based CBD maker Folium Biosciences has put its CBD extraction and purification facility up for sale before it was ever used. The property listing, by Hilco Commercial Industrial, LLC, a …
Colorado CBD maker puts factory up for sale before it was ever used Read More »
U.S. CBD company Charlotte’s Web Holdings (CW) will pay Major League Baseball $30.5 million plus a 10% royalty on sales, and grant the professional sports organization 4% of the company’s …
U.S. CBD company inks sponsorship deal with professional baseball league Read More »
Canada’s RAMM Pharma Corp. said it has purchased European CBD maker HemPoland from The Green Organic Dutchman Holdings Ltd. (TGOD) for roughly $920,000 (C$1.2 million) in cash. TGOD, Mississauga, Ontario, paid …
Canadian deal brutally illustrates CBD sector’s loss in value Read More »
New York-based biotech company 22nd Century Group, Inc. said it has started integration with GVB Biopharma after swapping $60-65 million in stock for 100% of the Las Vegas-based CBD company …
New York biotech company trades $60 million in stock for CBD group Read More »
Brewing giant Anheuser-Busch InBev said it will continue to develop CBD-infused non-alcoholic drinks in Canada after its joint venture with cannabis producer Tilray was dissolved this week. The two companies …
Beer, cannabis giants end joint venture that had planned to make drinks Read More »
Pharmaceutical giant Pfizer said it plans to buy San Diego-based Arena Pharmaceuticals, Inc., which is researching and developing cannabinoid-based medicines for patients who suffer gastrointestinal disorders, the companies announced this …
Pfizer to pay $6.7 billion for developer of cannabinoid medicines Read More »
